Jami Rubin serves as Executive at Relay Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Jami Rubin has executed 3 insider transactions totaling $500.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 10, 2024 involved exercising options for 42,242 shares valued at $212.9K.
Jami Rubin currently holds 67,242 shares of Relay Therapeutics, Inc. (RLAY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jami Rubin has been a net buyer of RLAY stock. They have purchased $500.0K and sold $0 worth of shares.
Jami Rubin's most recent insider trade was on Jun 10, 2024, when they sold 42,242 shares at $5.04 per share.
Get notified when new Form 4 filings are submitted
| 2,194,500 |
| $N/A |
| Discretionary |
| Jul 20, 2020 | RLAY | $500.0K | Purchase | 25,000 | $20.00 | Discretionary |